Euclidean Technologies Management LLC purchased a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 263 shares of the biopharmaceutical company’s stock, valued at approximately $216,000. A number of other institutional investors and […]
Gilman Hill Asset Management LLC increased its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3.4% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,736 shares of the biopharmaceutical company’s stock after buying an additional […]
HB Wealth Management LLC grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) by 28.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 702 shares of the biopharmaceutical company’s stock after purchasing an additional 154 shares during the period. HB Wealth […]
OneAscent Financial Services LLC grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) by 17.8% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 502 shares of the biopharmaceutical company’s stock after purchasing an additional 76 shares during the period. OneAscent Financial Services LLC’s holdings in Regeneron Pharmaceuticals were worth […]
Gulf International Bank UK Ltd cut its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) by 23.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,666 shares of the biopharmaceutical company’s stock after selling 4,300 shares during the period. Gulf […]